PDZRN4: A Potential Drug Target and Biomarker (G29951)

Target Name: PDZRN4

NCBI ID: G29951

PDZRN4

PDZRN4: A Potential Drug Target and Biomarker

The protein encoded by the PDZRN4 gene is a member of the PDZ domain-containing RING finger protein (PDZRFP) family, which is characterized by the presence of a PDZ domain in its extracellular domain. PDZ domains are a type of transmembrane protein that play a variety of roles in various cellular processes, including cell signaling, gene regulation, and intracellular signaling. The PDZ domain-containing RING finger protein (PDZRFP) is a family of proteins that share a common ancestor and are characterized by the presence of a PDZ domain in their extracellular domain.

PDZRN4 is a protein that is expressed in various tissues and cells of the human body, including the brain, pancreas, and muscle. It is involved in a variety of cellular processes, including cell signaling, gene regulation, and intracellular signaling. PDZRN4 has been shown to play a role in the regulation of cellular processes that are important for brain development, function, and disease.

One of the key functions of PDZRN4 is its role in the regulation of the Shh gene, which is a critical regulator of cell signaling and development. The Shh gene is a transcription factor that is involved in the regulation of a wide variety of cellular processes, including cell signaling, gene regulation, and intracellular signaling. PDZRN4 has been shown to play a role in the regulation of the Shh gene by binding to its extracellular domain and preventing it from activating its intracellular domain.

PDZRN4 is also involved in the regulation of theNotch gene, which is a transmembrane protein that is involved in a variety of cellular processes, including cell signaling and gene regulation. TheNotch gene is a critical regulator of cell signaling and has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders. PDZRN4 has been shown to play a role in the regulation of the Notch gene by binding to its extracellular domain and preventing it from activating its intracellular domain.

PDZRN4 has also been shown to play a role in the regulation of the Marfan gene, which is a transmembrane protein that is involved in the regulation of cell signaling and gene expression. The Marfan gene is a critical regulator of cell signaling and has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders. PDZRN4 has been shown to play a role in the regulation of the Marfan gene by binding to its extracellular domain and preventing it from activating its intracellular domain.

In addition to its role in the regulation of the Shh, Notch, and Marfan genes, PDZRN4 has also been shown to play a role in the regulation of a wide variety of other genes, including the TGF-β gene, which is involved in cell signaling and gene regulation. The TGF-β gene is a critical regulator of cell signaling and has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders. PDZRN4 has been shown to play a role in the regulation of the TGF-β gene by binding to its extracellular domain and preventing it from activating its intracellular domain.

PDZRN4 has also been shown to play a role in the regulation of the NF-kappa-B gene, which is involved in cell signaling and gene regulation. The NF-kappa-B gene is a critical regulator of cell signaling and has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders. PDZRN4 has been shown to play a role in the regulation of the NF-kappa-B gene by binding to its extracellular domain and preventing it from activating its intracellular domain.

PDZRN4 has also been shown to play a role in the regulation of the

Protein Name: PDZ Domain Containing Ring Finger 4

The "PDZRN4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDZRN4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets